April 13, 2021

Advanced Proteome Therapeutics Announces Closing Final Tranche of Non-brokered Private Placement

2021-09-09T12:52:14-04:00

Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8) is pleased to announce that, further to its news release of March 11, 2021 and subject to the approval of the TSX Venture Exchange, it has closed the final tranche of its non-brokered private placement (the “Private Placement”) raising gross proceeds of $524,610 by the issuance of 2,559,073 units at a price of $0.205 per unit.

Advanced Proteome Therapeutics Announces Closing Final Tranche of Non-brokered Private Placement2021-09-09T12:52:14-04:00
April 7, 2021

Advanced Proteome Therapeutics Announces Options Grants

2021-09-09T12:52:53-04:00

Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8), announces that it has granted 300,000 incentive stock options to consultants. The incentive stock options have an exercise price of $0.40 per share, are valid for a 2-year period from the date of grant, and are subject to regulatory approval.

Advanced Proteome Therapeutics Announces Options Grants2021-09-09T12:52:53-04:00
April 5, 2021

Advanced Proteome Therapeutics Announces Closing of Second Tranche of Non-Brokered Private Placement

2021-09-09T12:53:57-04:00

Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8) is pleased to announce that, further to its news release of March 11, 2021 and subject to the approval of the TSX Venture Exchange, it has closed the second tranche of its non-brokered private placement (the “Private Placement”) raising gross proceeds of $341,735 by the issuance of 1,667,000 units at a price of $0.205 per unit.

Advanced Proteome Therapeutics Announces Closing of Second Tranche of Non-Brokered Private Placement2021-09-09T12:53:57-04:00
Go to Top